Business Description
Pharma-Bio Serv Inc
NAICS : 621610
SIC : 8099
ISIN : US71711N1000
Description
Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It has three reportable segments: Puerto Rico technical compliance consulting which is the key revenue driver; United States technical compliance consulting; and Europe technical compliance consulting. The company offers solutions to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies. It generates maximum revenue from Puerto Rico and also has its presence in United States, Europe and Other countries.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 51.26 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.54 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.98 | |||||
| Beneish M-Score | -3.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -7.6 | |||||
| 3-Year EBITDA Growth Rate | -17.1 | |||||
| 3-Year EPS without NRI Growth Rate | -13.8 | |||||
| 3-Year FCF Growth Rate | 9.2 | |||||
| 3-Year Book Growth Rate | -10.8 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.76 | |||||
| 9-Day RSI | 27.11 | |||||
| 14-Day RSI | 31.11 | |||||
| 6-1 Month Momentum % | -6.54 | |||||
| 12-1 Month Momentum % | -22.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.1 | |||||
| Quick Ratio | 5.1 | |||||
| Cash Ratio | 4.32 | |||||
| Days Sales Outstanding | 98.19 | |||||
| Days Payable | 48.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | 0.98 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 28.85 | |||||
| Operating Margin % | 2.32 | |||||
| Net Margin % | 4.06 | |||||
| FCF Margin % | 11.52 | |||||
| ROE % | 3.87 | |||||
| ROA % | 3.07 | |||||
| ROIC % | 8.68 | |||||
| ROC (Joel Greenblatt) % | 12.77 | |||||
| ROCE % | 2 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.93 | |||||
| PE Ratio without NRI | 25.93 | |||||
| Shiller PE Ratio | 17.5 | |||||
| Price-to-Owner-Earnings | 7.61 | |||||
| PS Ratio | 1.07 | |||||
| PB Ratio | 1.13 | |||||
| Price-to-Tangible-Book | 1.13 | |||||
| Price-to-Free-Cash-Flow | 9.21 | |||||
| Price-to-Operating-Cash-Flow | 9.21 | |||||
| EV-to-EBIT | 1.41 | |||||
| EV-to-EBITDA | 0.86 | |||||
| EV-to-Revenue | 0.03 | |||||
| EV-to-FCF | 1.6 | |||||
| Price-to-Projected-FCF | 0.74 | |||||
| Price-to-Median-PS-Value | 1.03 | |||||
| Price-to-Graham-Number | 1.15 | |||||
| Price-to-Net-Current-Asset-Value | 1.17 | |||||
| Price-to-Net-Cash | 1.49 | |||||
| Earnings Yield (Greenblatt) % | 70.92 | |||||
| FCF Yield % | 10.83 | |||||
| Forward Rate of Return (Yacktman) % | -21.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PBSV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharma-Bio Serv Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 15.118 | ||
| EPS (TTM) ($) | 0.027 | ||
| Beta | 0.79 | ||
| Volatility % | 44.86 | ||
| 14-Day RSI | 31.11 | ||
| 14-Day ATR ($) | 0.03439 | ||
| 20-Day SMA ($) | 0.8168 | ||
| 12-1 Month Momentum % | -22.33 | ||
| 52-Week Range ($) | 0.65 - 1.1 | ||
| Shares Outstanding (Mil) | 22.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharma-Bio Serv Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharma-Bio Serv Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pharma-Bio Serv Inc Frequently Asked Questions
What is Pharma-Bio Serv Inc(PBSV)'s stock price today?
The current price of PBSV is $0.70. The 52 week high of PBSV is $1.10 and 52 week low is $0.65.
When is next earnings date of Pharma-Bio Serv Inc(PBSV)?
The next earnings date of Pharma-Bio Serv Inc(PBSV) is .
Does Pharma-Bio Serv Inc(PBSV) pay dividends? If so, how much?
Pharma-Bio Serv Inc(PBSV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers